Apollo Medical (NASDAQ:AMEH) Cut to Hold at ValuEngine

ValuEngine downgraded shares of Apollo Medical (NASDAQ:AMEH) from a buy rating to a hold rating in a research report released on Tuesday, ValuEngine reports.

A number of other analysts have also weighed in on the stock. TheStreet upgraded shares of Apollo Medical from a d rating to a c- rating in a research note on Friday, June 28th. Zacks Investment Research lowered shares of Apollo Medical from a hold rating to a strong sell rating in a research note on Friday, August 9th.

NASDAQ:AMEH opened at $16.57 on Tuesday. The firm has a market cap of $565.42 million, a P/E ratio of 57.14, a P/E/G ratio of 9.55 and a beta of -0.80. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.14 and a current ratio of 2.14. Apollo Medical has a fifty-two week low of $13.36 and a fifty-two week high of $23.32. The firm has a 50-day simple moving average of $15.29 and a two-hundred day simple moving average of $17.76.

In other Apollo Medical news, insider Adrian Vazquez sold 85,000 shares of the firm’s stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $16.35, for a total transaction of $1,389,750.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Kenneth T. Sim acquired 6,996 shares of Apollo Medical stock in a transaction on Wednesday, June 12th. The shares were purchased at an average price of $14.50 per share, with a total value of $101,442.00. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 33,036 shares of company stock valued at $487,448. 11.83% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Apollo Medical by 9.6% during the 2nd quarter. Vanguard Group Inc. now owns 1,164,827 shares of the company’s stock valued at $19,464,000 after acquiring an additional 102,267 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of Apollo Medical by 98.7% in the second quarter. BlackRock Inc. now owns 728,124 shares of the company’s stock worth $12,167,000 after buying an additional 361,766 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Apollo Medical by 14.3% in the fourth quarter. Geode Capital Management LLC now owns 183,445 shares of the company’s stock worth $3,641,000 after buying an additional 22,917 shares during the last quarter. Northern Trust Corp boosted its holdings in shares of Apollo Medical by 33.2% in the fourth quarter. Northern Trust Corp now owns 111,883 shares of the company’s stock worth $2,221,000 after buying an additional 27,894 shares during the last quarter. Finally, Manchester Financial Inc. boosted its holdings in shares of Apollo Medical by 18.5% in the first quarter. Manchester Financial Inc. now owns 92,621 shares of the company’s stock worth $1,697,000 after buying an additional 14,453 shares during the last quarter. 7.59% of the stock is currently owned by hedge funds and other institutional investors.

About Apollo Medical

Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Further Reading: What are the benefits of investing in REITs?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.